دانلود ها
- کل دانلودها ۴۹۸
دارورسانی با نانوذرات هدفمند: روشهای ارزیابی برونتنی و درونتنی
Drug Delivery with Targeted Nanoparticles
In Vitro and In Vivo Evaluation Methods
Jenny Stanford | انتشارات |
2022 | سال انتشار |
اول | ویرایش |
789 | تعداد صفحات |
Yılmaz Çapan Adem Sahin Hayrettin Tonbul |
نویسندگان/ویراستارها |
فهرست کتاب:
1- Particle Size Determination of Targeted Nanoparticles
2- Zeta Potential Determination of Targeted Nanoparticles
3- Stability of Targeted Nanoparticles
4- Impact of PEGylation on Targeted Nanoparticulate Delivery
5- Ligands and Receptors for Targeted Delivery of Nanoparticles: Recent Updates and Challenges
6- Characterization of Biological Molecule–Loaded Nanostructures Using Circular Dichroism and Fourier Transform Infrared Spectroscopy
7- Evaluation of Stimuli-Sensitive Nanoparticles in vitro
8- Analytical Techniques for Characterization of Nanodrugs
9- Cytotoxicity and Biological Compatibility
10- Cellular Uptake and Transcytosis
11- Evaluation of 3D Cell Culture Models for Efficacy Determination of Anticancer Nanotherapeutics
12- In vitro and in vivo Blood–Brain Barrier Models for the Evaluation of Drug Transport with Targeted Nanoparticles
13- Sterility Evaluation of Targeted Nanoparticles
14- Evaluation of Pharmacokinetics and Biodistribution of Targeted Nanoparticles
15- Evaluation of the in vivo Preclinical Toxicity of Targeted Nanoparticles
16- Transdermal Delivery of Targeted Nanoparticles and in vitro Evaluation
17- In vivo and in vitro Evaluation of Nose-to-BrainDelivery of Nanoparticles
18- Evaluation of Targeted Nanoparticles for Ocular Delivery
19- Vaginally Applied Nanocarriers and Their Characterizations
20- Oral Administration of Nanoparticles and Approaches for Design, Evaluation, and State of the Art
21- Drug Resistance Mechanisms and Strategies to Overcome Drug Resistance with Nanoparticulate Systems
22- Clinical Trials of Targeted Nanoparticulate Drug Delivery Systems
23- Evaluation of Targeted Mesoporous Silica Nanoparticles
24- Evaluation of Targeted Liposomes
25- Prospects of Nanomedicine with Nanocrystal Technology
26- Characteristics of Marketed Nanopharmaceutics
27- Regulatory Guidelines of the US Food and Drug Administration and the European Medicines Agency for Actively Targeted Nanomedicines